Thromboxane biosynthesis in cancer patients and its inhibition by aspirin: a sub-study of the Add-Aspirin trial.

Autor: Joharatnam-Hogan N; MRC Clinical Trials Unit, UCL, London, UK., Hatem D; Department of Safety and Bioethics, Division of Pharmacology, Catholic University School of Medicine, Rome, Italy., Cafferty FH; MRC Clinical Trials Unit, UCL, London, UK.; The Institute of Cancer Research, London, UK., Petrucci G; Department of Safety and Bioethics, Division of Pharmacology, Catholic University School of Medicine, Rome, Italy., Cameron DA; Cancer Research UK Edinburgh Centre, Institute of Genetics and Cancer, The University of Edinburgh, Western General Hospital, Edinburgh, UK., Ring A; The Institute of Cancer Research, London, UK.; The Royal Marsden NHS Foundation Trust, London, UK., Kynaston HG; Department of Urology, Cardiff University School of Medicine, Cardiff, UK., Gilbert DC; MRC Clinical Trials Unit, UCL, London, UK.; University Hospitals Sussex NHS Foundation Trust, Brighton, UK., Wilson RH; School of Cancer Sciences, University of Glasgow, Glasgow, UK.; The Beatson West of Scotland Cancer Centre, Glasgow, UK., Hubner RA; The Christie NHS Foundation Trust, Department of Medical Oncology, Manchester, UK.; University of Manchester, Division of Cancer Sciences, Manchester, UK., Swinson DEB; Leeds Teaching Hospitals NHS Trust, Leeds, UK., Cleary S; MRC Clinical Trials Unit, UCL, London, UK., Robbins A; MRC Clinical Trials Unit, UCL, London, UK., MacKenzie M; Independent Cancer Patients' Voice, London, UK., Scott-Brown MWG; University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK., Sothi S; University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK., Dawson LK; Edinburgh Cancer Centre, Western General Hospital, Edinburgh, UK., Capaldi LM; Worcestershire Acute Hospitals NHS Trust, Worcester, UK., Churn M; Worcestershire Acute Hospitals NHS Trust, Worcester, UK., Cunningham D; The Royal Marsden NHS Foundation Trust, London, UK., Khoo V; The Institute of Cancer Research, London, UK.; The Royal Marsden NHS Foundation Trust, London, UK., Armstrong AC; The Christie NHS Foundation Trust, Department of Medical Oncology, Manchester, UK., Ainsworth NL; The Queen Elizabeth Hospital King's Lynn NHS Foundation Trust, King's Lynn, UK., Horan G; The Queen Elizabeth Hospital King's Lynn NHS Foundation Trust, King's Lynn, UK., Wheatley DA; Royal Cornwall Hospitals NHS Trust, Cornwall, UK., Mullen R; The Highland Breast Centre, Raigmore Hospital, Inverness, UK., Lofts FJ; St George's University Hospitals NHS Foundation Trust, London, UK., Walther A; University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK., Herbertson RA; University Hospitals Sussex NHS Foundation Trust, Brighton, UK., Eaton JD; University Hospitals of Morecambe Bay NHS Foundation Trust, Kendal, UK., O'Callaghan A; Portsmouth Hospitals University NHS Trust, Portsmouth, UK., Eichholz A; Buckinghamshire Healthcare NHS Trust, Buckinghamshire, UK., Kagzi MM; South Tees Hospitals NHS Foundation Trust, Middlesbrough, UK., Patterson DM; West Suffolk Hospitals NHS Trust, St Edmunds, UK., Narahari K; University Hospital of Wales, Cardiff and Vale University Health Board, Cardiff, UK.; Division of Cancer and Genetics, Cardiff University, Cardiff, UK., Bradbury J; Salisbury NHS Foundation Trust, Salisbury, UK., Stokes Z; United Lincolnshire Hospitals NHS Trust, Lincoln City, UK., Rizvi AJ; Milton Keynes University Hospital NHS Foundation Trust, Milton Keynes, UK., Walker GA; Nottingham University Hospitals NHS Trust, Nottingham, UK., Kunene VL; Walsall Manor Hospital and University Hospitals, Birmingham NHS Foundation Trust, Birmingham, UK., Srihari N; Shrewsbury and Telford Hospital NHS Trust, Shrewsbury, UK., Gentry-Maharaj A; MRC Clinical Trials Unit, UCL, London, UK., Meade A; MRC Clinical Trials Unit, UCL, London, UK., Patrono C; Department of Safety and Bioethics, Division of Pharmacology, Catholic University School of Medicine, Rome, Italy., Rocca B; Department of Safety and Bioethics, Division of Pharmacology, Catholic University School of Medicine, Rome, Italy., Langley RE; MRC Clinical Trials Unit, UCL, London, UK. ruth.langley@ucl.ac.uk.

Publikováno v: British journal of cancer [Br J Cancer] 2023 Sep; Vol. 129 (4), pp. 706-720. Date of Electronic Publication: 2023 Jul 07.

Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer.

Autor: Cunningham D; Department of Medicine, Royal Marsden Hospital, Sutton , Surrey, United Kingdom. david.cunningham@rmh.nhs.uk, Allum WH, Stenning SP, Thompson JN, Van de Velde CJ, Nicolson M, Scarffe JH, Lofts FJ, Falk SJ, Iveson TJ, Smith DB, Langley RE, Verma M, Weeden S, Chua YJ, MAGIC Trial Participants

Publikováno v: The New England journal of medicine [N Engl J Med] 2006 Jul 06; Vol. 355 (1), pp. 11-20.

A phase II trial of the vitamin D analogue Seocalcitol (EB1089) in patients with inoperable pancreatic cancer.

Autor: Evans TR; CRC Department of Medical Oncology, Beatson Oncology Centre, Western Infirmary, Dumbarton Road, Glasgow G11 6NT, UK. J.Evans@beatson.gla.ac.uk, Colston KW, Lofts FJ, Cunningham D, Anthoney DA, Gogas H, de Bono JS, Hamberg KJ, Skov T, Mansi JL

Publikováno v: British journal of cancer [Br J Cancer] 2002 Mar 04; Vol. 86 (5), pp. 680-5.

Adenocarcinoma of the gall bladder presenting with haematuria.

Autor: Brock JE, Ahmed A, Lofts FJ

Publikováno v: Clinical oncology (Royal College of Radiologists (Great Britain)) [Clin Oncol (R Coll Radiol)] 2001; Vol. 13 (1), pp. 65-6.

Phase I study of ONO-4007, a synthetic analogue of the lipid A moiety of bacterial lipopolysaccharide.

Autor: de Bono JS; Cancer Research Campaign Department of Medical Oncology, Beatson Oncology Centre, Western Infirmary, Glasgow, United Kingdom. gpmv08@udcf.gla.ac.uk, Dalgleish AG, Carmichael J, Diffley J, Lofts FJ, Fyffe D, Ellard S, Gordon RJ, Brindley CJ, Evans TR

Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2000 Feb; Vol. 6 (2), pp. 397-405.